BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9150782)

  • 1. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF; Freysz M; Faucon G; Loufoua-Moundanga J; Coquelin H; Timour Q
    Acta Anaesthesiol Scand; 1997 Apr; 41(4):516-23. PubMed ID: 9150782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
    Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua J; Faucon G; Timour Q
    Cardiovasc Res; 1996 Dec; 32(6):1056-63. PubMed ID: 9035900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration.
    Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q
    Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].
    Timour Q; Aupetit JF; Loufoua-Moundanga JL; Barral-Cadière L; Freysz M; Faucon G
    Therapie; 1994; 49(4):349-53. PubMed ID: 7878603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Kioueh I; Omar S; Chevrel G; Faucon G
    Fundam Clin Pharmacol; 1992; 6(4-5):159-67. PubMed ID: 1427561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of a beneficial effect into an untoward effect by ischaemia: effect of quinidine-like drugs on vulnerability to ventricular fibrillation.
    Aupetit JF; Freysz M; Faucon G; Loufoua J; Timour Q
    Environ Toxicol Pharmacol; 1996 Aug; 2(1):1-7. PubMed ID: 21781694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of magnesium on ischemic and reperfusion arrhythmias in a canine model with diminished collateral blood flow.
    Euler DE
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):565-71. PubMed ID: 8547206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Gerentes-Chassagne I; Kioueh I; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):645-51. PubMed ID: 1944606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.
    Aupetit JF; Timour Q; Chevrel G; Loufoua-Moundanga J; Omar S; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):509-14. PubMed ID: 8114951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.
    Aupetit JF; Timour Q; Larbre JP; Loufoua-Moundanga J; Kioueh I; Lopez M; Faucon G
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):217-23. PubMed ID: 8357775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
    Timour Q; Larbre JP; Kioueh I; Aupetit JF; Loufoua-Moundanga J; Vialle A; Faucon G
    Arch Int Pharmacodyn Ther; 1992; 315():30-46. PubMed ID: 1384452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
    Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
    Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischaemia. A randomised study in pigs.
    Andersen HR; Wiggers H; Knudsen LL; Simonsen I; Thomsen PE; Christiansen N
    Cardiovasc Res; 1994 Nov; 28(11):1635-40. PubMed ID: 7842456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
    Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
    Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
    Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
    Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.